Sorry, you need to enable JavaScript to visit this website.

CHAMPIX (varenicline tartrate) Overdosage

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.



Consistent with its pharmacological profile, CHAMPIX resulted in increased incidences of nausea and vomiting when given at doses greater than the recommended dose of 1 mg BID.


Varenicline has been shown to be dialyzed in patients with end-stage renal disease (see ACTION AND CLINICAL PHARMACOLOGY, Special Populations and Conditions: Renal Insufficiency), however, there is no experience with dialysis following overdose.

For management of a suspected drug overdose, contact your regional Poison Control Centre.

What's New

No Current Announcements.

Other Resources

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111